Castle Biosciences Form 4 Filed by Juvenal Tobin W
A Form 4 for Castle Biosciences was filed by Juvenal Tobin W. The filing date shown is October 28; the reported transaction date is October 26.
Related stories
Hershey Shares Fall 2% as Company Warns of Halloween Consumer Pressure
Hershey shares are down 2% after the company warned of consumer pressure during Halloween.
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC
Novavax Eligible for Royalties and $75 Million Milestone Payment
Novavax is eligible for royalties and a $75 million milestone payment on a technology transfer in mid-2027.
L impact | EQUITY | Oct 29, 2026, 01:41 PM UTC
Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Trial
Sanofi launched a Phase 3 trial in Europe of its influenza-COVID-19 combination vaccine. Novavax earned a $125 million milestone.
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC
China Energy Engineering Says Q3 Revenue Fell 9.5% YoY
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC
Bunge’s Quarterly Profit Beats Forecasts on Strong Crushing Margins
Bunge reported quarterly profit above forecasts, citing strong crushing margins.
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC
China Energy Engineering Q3 Net Profit Falls 4.9% Year Over Year
China Energy Engineering said third-quarter net profit fell 4.9% year over year.
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC